Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 2
2011 1
2013 3
2014 1
2016 1
2017 2
2018 1
2020 1
2021 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial.
Walsh M, Collister D, Gallagher M, Mark PB, de Zoysa JR, Tyrwhitt J, Tennankore K, Reis G, Xavier D, Liu WJ, Zuo L, Wang AY, Félix C, Sola L, Arici M, Villanueva R, Jha V, Précoma D, Rabbat CG, Alavudeen SS, Faruqui AR, López-Flecher M, Pyne L, Wald R, Yuan F, Balasubramanian K, Lee SF, Kuptsova A, Christou C, Devereaux PJ; ACHIEVE Investigators. Walsh M, et al. Lancet. 2025 Aug 16;406(10504):695-704. doi: 10.1016/S0140-6736(25)01198-5. Lancet. 2025. PMID: 40818850 Clinical Trial.
Association of Clonal Hematopoiesis of Indeterminate Potential with Cardiovascular Events in Patients with CKD.
Pan Y, Vlasschaert C, Rao V, Akwo EA, Hixson JE, Uddin MM, Yu Z, Kim DK, Bick A, Kestenbaum B, Chong M, Paré G, Rauh M, Levin A, Lash JP, Kurella Tamura M, Cohen DL, He J, Hamm L, Deo R, Bhat Z, Rao P, Xie D, Natarajan P, Kelly TN, Robinson-Cohen C, Lanktree MB; Canadian Study of Prediction of Death, Dialysis and Interim Cardiovascular Events (CanPREDDICT) and Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Pan Y, et al. J Am Soc Nephrol. 2025 Apr 9;36(9):1775-1785. doi: 10.1681/ASN.0000000671. J Am Soc Nephrol. 2025. PMID: 40202812
Advancing Palliative Care in Patients With CKD: From Ideas to Practice.
Chiu HH, Murphy-Burke DM, Thomas SA, Melnyk Y, Kruthaup-Harper AL, Dong JJ, Djurdjev O, Saunders S, Levin A, Karim M, Hargrove GM; BC Renal Palliative Care Committee. Chiu HH, et al. Am J Kidney Dis. 2021 Mar;77(3):420-426. doi: 10.1053/j.ajkd.2020.09.012. Epub 2020 Nov 9. Am J Kidney Dis. 2021. PMID: 33181264 Free article.
15 results